AI IS WHERE THE DATA IS
LIVE

Serial Number

90812123

Owner

immatics biotechnologies GmbH

Attorney

Anna Kurian Shaw

Filing Date

Jul 6, 2021

Add to watchlist:

No watchlists yet
View on USPTO

AI IS WHERE THE DATA IS Trademark

Serial Number: 90812123 • Registration: 6693951

AI IS WHERE THE DATA IS is a trademark filed by immatics biotechnologies GmbH on July 6, 2021. The trademark is classified under Class 9 (Computers & Electronics), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

immatics biotechnologies GmbH (40 trademarks)

Tübingen 72076 , DE

Entity Type: 99

Trademark Details

Filing Date

July 6, 2021

Registration Date

April 5, 2022

Published for Opposition

January 18, 2022

Goods & Services

Bioinformatics software; graphical user interface software; artificial intelligence and machine learning software for genome analysis, developing personal treatment strategies for patients with diagnosed cancer, analyzing, screening, identifying, quantifying, and interpreting data in the field of mass spectrometry and next-generation sequencing (NGS); electronic databases for bioinformatic purposes; next-generation sequencing (NGS) data processor; bioinformatics data processor; computer software

Statistical services and modeling with respect to cancer treatment and cancer diagnosis

Medical and pharmaceutical services

Computer programming in the medical, pharmaceutical and biotechnological field; database design; database maintenance; programming of software for importing and managing data; information technology services for the pharmaceutical and healthcare industries; Computer programming for data processing; non-downloadable computer software; conducting evaluations in the field of pharmaceuticals; consulting services in the fields of biotechnology and pharmaceutical research; pharmaceutical product development and evaluation services; pharmaceutical research and development; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; research and development of pharmaceuticals for the treatment of cancer; technical research in the field of pharmaceutical studies; development of platform technology, namely, cancer immunotherapy platforms for manufacturing therapeutics; conducting clinical trials in the field of pharmaceuticals for the treatment and prevention of cancer; collection of specific molecular and genomic data for analytical and clinical purposes, for the treatment of cancer and other diseases and disorders and for individuals' responses to drug treatments; research and development of medicines and diagnostic agents for cancer treatment and cancer diagnosis; providing scientific advice in the fields of cancer biology, cancer treatment, pharmaceutical side effects, genomics, cancer medicine and translational medicine; providing scientific analysis in the field of next-generation sequencing (NGS) with respect to the analysis and interpretation of genomic data obtained from cancer patients; providing an online, non-downloadable computer software platform for purposes of storing and providing information about an individual's cancer profile and genomic changes to enable physicians and healthcare professionals to optimize treatment in clinical practice; research and development services in the field of immunology

Filing History

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Nov 2, 2022 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 2, 2022 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Nov 2, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Nov 2, 2022 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Nov 2, 2022 COAR
REGISTERED-PRINCIPAL REGISTER
Apr 5, 2022 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 18, 2022 NPUB
PUBLISHED FOR OPPOSITION
Jan 18, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 29, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 11, 2021 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 10, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 10, 2021 CRFA
ASSIGNED TO LIE
Dec 9, 2021 ALIE
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Dec 6, 2021 ERSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Sep 21, 2021 GNS3
LETTER OF SUSPENSION E-MAILED
Sep 21, 2021 GNSL
SUSPENSION LETTER WRITTEN
Sep 21, 2021 CNSL
ASSIGNED TO EXAMINER
Sep 21, 2021 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 14, 2021 NWOS
NEW APPLICATION ENTERED
Jul 9, 2021 NWAP